<DOC>
	<DOCNO>NCT01914211</DOCNO>
	<brief_summary>This observational , prospective study evaluate role tranexamic acid reduce blood transfusion neonates undergoing cardiopulmonary bypass .</brief_summary>
	<brief_title>The Role Tranexamic Acid Reducing Blood Transfusion Requirements After Cardiopulmonary Bypass Neonates</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>All neonate undergo arterial switch aortic arch procedure utilize cardiopulmonary bypass ( CPB ) . Jehovah 's witness patient .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>